New Scientist - When Big Pharma Breaks the Law, Prosecute the CEO
Patient safety will remain at risk until big pharma's top executives are brought to book for their companies' actions, saysPaul Thacker
THERE have been so many stories about pharmaceutical companies promoting the misuse or abuse of their drugs that the names seem to merge - Zyprexa, Seroquel, Paxil and more.
The latest case concerns GlaxoSmithKline's Avandia (rosiglitazone), an anti-diabetes drug linked to heart attacks. Last month, the European Medicines Agency recommended its suspension from the market, while the US Food and Drug Administration made it all but impossible for doctors to write prescriptions for the drug.